In addition, the levels of total tau, phosphorylated tau181, and glial fibrillary acidic protein, all biomarkers for AD, were elevated in SARS-CoV-2-infected patients with severe symptoms, suggesting a potential correlation between AD and SARS-CoV-2 infection severity56. This evidence concerns the gene GFAP and Alzheimer disease.